The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

CNW/ - Pancreatic Cancer North America (PCNA) is launching a new national pilot that will provide pancreatic cancer patients ...

After a cancer diagnosis, patients often have many questions, not only about their treatment but also about what the ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

On-site automated NGS using circulating tumor DNA enabled comprehensive genomic testing in ~27 hours, substantially shortening the interval between diagnosis and potential targeted-therapy selection.

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, ...

How Targeted Therapy Works In Cancer Care: Cancer begins when changes occur in the genetic structure of the body's cells.

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment. Heather Quintana Suchan, a ...